Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization - Buckley, B C; Roylance, D; Mitchell, M P; Patel, S M; Cannon, H E; Dunn, J D (J Manag Care Pharm, 2010)